Despite the shift to patient-centered care in recent years, many clinical studies continue to reinforce the traditional researcher/subject relationship. In contrast, action research engages study participants in a collaborative relationship with researchers. Objectives: To review the benefits of adding a participatory component to an existing study with respect to (1) engaging participants in the research process to clarify and validate qualitative findings, (2) engaging participants in the change process to develop potential solutions for improving integrative cancer services, and (3) giving voice to the concerns of patients using complementary and alternative medicine. Method: Focus groups were used to clarify concepts arising from patient interviews and to provide a forum for participants to develop recommendations and facilitate dissemination. Conclusion: Our approach empowered patients by involving them in the research and in developing solutions for how health care providers, policy makers, and researchers can enhance an integrative approach to cancer care.
Clinical research often treats study participants as people (subjects) who passively follow the investigator's direction and have no input in the process and conduct of the research. In contrast, action research engages study participants in a collaborative relationship with researchers. Bowling 1 defined action research as involving "a participatory and consensual approach towards investigating problems and developing plans to deal with them." Rather than being treated as research subjects, researchers encourage study participants to act on their own behalf in bringing about change. While there has been a shift to patientcentered care in recent years, clinical research, which is often quantitative, continues to reinforce the traditional researcher/subject relationship, including high control of the research process and limited attention to patient experiences and patient-defined outcomes. This is much less so in qualitative research, but even in this type of research, patients are often not provided the opportunity to take some degree of control of the research process.
Participatory action research, by definition, is rooted in the experience of the people in the study. Qualitative inquiry that seeks patient input into the evaluation of interventions or services may reveal clinically important patient-defined outcomes that would not have been identified otherwise. This is especially important for complementary and alternative medicine (CAM) research, as the treatment preferences of patients using a holistic approach may differ from those who seek a traditional biomedical approach (eg, curing vs healing). In the traditional approach to medical research, study participants are not involved directly in the research process. In this study, we focused on involving participants in the validation and dissemination of the study findings. Researchers usually develop clinical recommendations based on their interpretation of the research results and disseminate findings at health conferences and in medical journals. Participatory research provides a way to add the patient perspective to recommendations, without undermining the researcher's perspective. Sharing study findings with research participants to disseminate to their family members, physicians, and community gives some control to the participant, without compromising the role of clinicians or researchers.
This article describes the benefits of action research, which involves a patient-centered approach in a study addressing cancer management decision making. This study integrates principles of participatory action research into a traditional research design. This method is well suited to CAM research as the desire for control over treatment decision making is characteristic for patients using CAM, [2] [3] [4] and in the same vein, these patients may also desire involvement in the research process. Drawing on our own study, we illustrate how a patient-centered approach can empower patients by involving them more directly in the research and change process and in developing solutions for how health care providers, policy makers, and researchers can support an integrative cancer care approach. At the same time, this approach strengthens the validity of the study findings.
Background
We are currently conducting a longitudinal study to assess decision making by men who forgo conventional treatment for prostate cancer and use CAM. CAM has been described as a group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine. 5 Participants in the study are men diagnosed with prostate cancer in the past 10 years who declined conventional cancer treatment and are using alternative therapies. Semistructured qualitative interviews were conducted at study entry to explore reasons for declining conventional cancer treatment and using alternative approaches.
Quantitative data are collected at baseline and at 5 follow-up intervals over a 3-year period to assess changes in treatment decision making, disease status, and psychosocial well-being. Because of the men's request for input into the study and their desire to meet other study participants, we added focus groups, which served as a participatory action component. Adding this component enhanced the overall goals of the study. First, it provided an additional source of qualitative data to explore in depth why men forgo conventional cancer treatment and use CAM. Second, it provided a method for asking participants to identify solutions for how health care providers could support them in the decision-making process, based on the problems and issues identified in the interviews. The objective of this article is to describe and discuss the usefulness of adding the participatory component with respect to engaging participants in the research process.
Objectives
As indicated above, the overall goal of our study is to increase the understanding of decision making about cancer management by men with prostate cancer who have decided to forgo conventional treatment. The objectives of adding the participatory research component were to discuss the usefulness of such an approach with respect to (1) engaging participants in the research process to clarify and validate preliminary findings, (2) engaging participants in the change process to develop potential solutions for improving integrative cancer services, and (3) giving voice to the concerns of men with prostate cancer in the medical community.
Method
The participatory component added to our study consisted of focus groups with study participants. Focus group methodology was used for 3 reasons. First, focus groups are helpful as they make use of the group dynamic to "stimulate discussion, gain insights and generate ideas in order to pursue a topic in greater depth." 1 This group process allows for (1) the generation of new insights into the study findings and (2) assessment of whether there is group consensus on major themes. Second, focus groups provide an additional source of information for validation of the qualitative analysis of the interview data. Validation by asking respondents to confirm the truth and coherence of the results enhances the meaning of the data. Fossey et al 6 advised that "multiple methods and/or sources of information to weigh in the analysis" be used to improve the quality of qualitative research. Third, focus groups involve study participants in the research and change process by providing a forum for them to meet and develop joint recommendations about health care services. Because alternative cancer therapy is a controversial health care issue and an area in which little research has been done, research into how the provision of health care services influences the decision to forgo conventional treatment will contribute significantly to the field.
Twenty study participants, who completed a baseline interview in the previous year, were invited to attend a focus group. Five participants did not attend. Reasons for not attending included "could not contact" (2 subjects), "out of the country" (1 subject) and "unknown" (2 subjects). Two focus groups were conducted consisting of 9 and 6 participants, respectively. Each meeting lasted 2 hours. The 2 study investigators, Marja Verhoef and Margaret White, facilitated the focus groups. The group discussion was tape recorded and transcribed in preparation for analysis.
The focus group was divided into 2 parts. During the first hour, study participants shared in a discussion of the preliminary findings of the interview data, exploring areas of consensus and disagreement on 5 key topic areas: (1) health beliefs about Western medicine and holistic health, (2) gathering and evaluating evidence about conventional cancer treatment, (3) decision-making control, (4) learning through the experience of others who have received cancer treatment, and (5) spirituality and healing. A strategy called "member checking" was used to establish validity of the qualitative data. 6 Validation techniques that were specifically developed for focus groups by Richard Krueger 7 were used and consisted of asking 2 questions after presenting each topic: (1) "Do these findings accurately represent your experience?" and (2) "Is there anything we have missed that you feel should be included?" In addition, specific questions were asked for themes that required further exploration.
During the second hour of the focus group, study participants were engaged in a discussion to identify strategies regarding how health care providers could best support men with prostate cancer using CAM in treatment decision making. The facilitator asked participants to verify whether their comments recorded on a flip chart accurately reflected their ideas.
Benefits of a Patient-Centered Approach to Research Using Principles of Participatory Action Research
The focus groups benefited study participants in several ways. First, the focus groups provided social support to study participants who expressed a need to meet with other men who declined conventional treatment for prostate cancer. As the study employed multiple recruitment strategies across geographic regions, the focus group research acted as a catalyst to bring these men together around a shared interest. We had booked the room in which the focus group was held for an extra hour so that the participants could meet while the facilitators left. As we heard later, the men used this time to exchange e-mail addresses so they could network with each other. Second, the focus groups provided a way to empower study participants by asking them to provide input into whether the themes identified in the preliminary analysis were consistent with their experience. In doing so, the rigor of the qualitative analysis was also strengthened. Third, in the process of validating themes, we as researchers deepened our understanding of the issues and gained new insights from the group discussion. For example, spirituality was very important for some study participants, while others did not raise the issue in the individual interviews. The focus groups provided a way to explore the meaning of spirituality in a group context, broadening our understanding of the role of spirituality in the decision-making process. Fourth, the focus groups provided an opportunity for men with prostate cancer to voice their concerns and identify solutions for how physicians, government policy makers, and researchers can improve integrative cancer care services. At the request of the participants, their recommendations were featured in popular health magazines 8, 9 and presented at a medical conference. 10 Fifth, engaging study participants in the research process may have increased their commitment to the study, improving the completion rate of the longitudinal data. Subjective (qualitative) evidence from study participants supports this benefit.
The goal of participatory action research is to engage study participants in the research and change process by incorporating principles of action research. Below, we discuss ways in which our study was successful in meeting the criteria for action research, as defined by Hart and Bond's framework. 11 First, our study was educative in that study results were shared with participants and the focus group recommendations were disseminated in a variety of media. Second, participatory research deals with individuals as members of a social group. The focus groups provided social support and a forum for men with prostate cancer who use alternative therapies to discuss common concerns. Third, in participatory action research, the problem should be explored as part of a process of change, developing an understanding of meanings of issues in terms of problems and solutions. 11 The focus groups provided a methodology for researchers and participants to explore challenges encountered by men with prostate cancer using CAM and to identify solutions for improving integrative cancer care. Fourth, participatory research aims at involvement and improvement, taking into account that in controversial areas of health care, there may be differences between professionals and users of the service, about what counts as improvement. 11 The topic of our study was well suited to a participatory approach because using complementary medicine, in general, and declining conventional cancer treatment, in particular, are controversial issues within Western medicine and we do not know enough about how patients come to that decision. Fifth, participatory action research is based on a research relationship that involves participants in the change process. It aims to raise consciousness and to address an imbalance of power. 11 The study helped to acknowledge the power imbalance between patients and health care professionals by bringing patient recommendations forward at a medical conference, an arena to which patients traditionally have little access. Sixth, action research involves a cyclic process in which research, action, and evaluation are linked. 11 Study participants engaged in direct action by formulating recommendations for changing how health care providers communicate with and provide services to men seeking alternative approaches to prostate cancer treatment. The dissemination of the recommendations made their concerns visible and created the potential for future action to take place. Seventh, participatory research usually involves a change intervention. Although this was not an intervention study, it may have stimulated some participants to develop initiatives to address unmet needs identified in the research. For example, some participants developed educational presentations about holistic approaches to cancer care and others initiated support sessions for cancer patients who decline conventional treatment. Hart and Bond 11 suggested that "changing the ways in which problems are discussed . . . has the effect of initiating other changes. The first may not be the sole direct cause of the second, although it may be a contributory factor."
Conclusion
There were limits in our ability to transcend the boundaries between researcher and study participants. Our goal was to create a voice for patients within the scope of a clinical study rather than involve participants in all aspects of the study design, which is characteristic of many participatory action research projects. Within those boundaries, we were able to create an opportunity for study participants to have an independent voice and to bring that voice into health care policy and in the public arena. However, while the study brought their concerns into public view, the men themselves were not involved in these presentations. Nor is there a concrete intervention resulting directly from the research, as compared to community-based action research. The participatory component in our study was intended to influence public attitudes rather than make concrete changes in community health services. Building a participatory action component into the study design strengthened the qualitative interview data by using additional sources of validation and by increasing commitment to the longitudinal study. Finally, creating an opportunity for men with prostate cancer to make their own recommendations for clinical practice provides health care professionals with study findings that are grounded in the issues meaningful to the people they serve. Bowling (quoting Stringer EJ) suggested that as a result of engaging people directly in the research process, we come closer to the reality of other people's experience and, in the process, increase the potential for creating truly effective services and programs that will enhance the lives of the people we serve. 1 By incorporating action research principles into our longitudinal study, we hope the research findings more accurately reflect the needs of men with prostate cancer who decline conventional cancer treatment and that these findings increase the potential for improving the delivery of integrative cancer care.
Given the growing need of patients to be involved in health care decision making, there is an increased interest in patient-centered care. We argue that this need also exists in research and that, as much as possible, studies should be participant centered as well, involving study participants in the research and change process. This article demonstrates that it is feasible to incorporate elements of participatory research into the design of clinical studies by building on qualitative components of research or by adding qualitative or action-oriented components. This approach simultaneously strengthens the validity of the qualitative analysis and empowers participants to become more involved in the delivery of health care services.
